LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing
ConclusionsOur findings identified a novel mechanism by which lncRNA CCAT2, as a type of protein-binding RNA,
regulates alternative splicing of CD44 and promotes GC progression. This axis may become an effective target for clinical diagnosis and treatment.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Epithelial Cancer | Gastric (Stomach) Cancer | Gastroenterology | Study